Australian Webinar: August 2025 Reporting Season
In this webinar, Portfolio Manager Stuart Welch provides an update on Alphinity’s view of the Australian August 2025 reporting season. Stuart shares key takeaways from results and discusses market themes.
Global Webcast: Initial Impressions from the 2Q25 US reporting season & Mag7 results
Elfreda Jonker speaks with Trent Masters about a strong but volatile second quarter reporting season. Tech leaders like Meta and Microsoft outperformed, while healthcare and consumer stocks lagged amid looming tariff impacts and margin pressures into 2026.
Australian Webcast: Aus vs US Healthcare Sectors & why we still like Resmed
Elfreda Jonker speaks with Stuart Walsh about why Australia’s healthcare sector has outperformed global peers, thanks to niche leaders like CSL, ResMed, and Cochlear that are less affected by US policy headwinds. ResMed in particular has benefited from strong demand, product innovation, and competitor exits, driving an ongoing earnings upgrade cycle and healthy shareholder returns.
Navigating nature-related risks in the farmed seafood supply chain
Nature is an increasing focus for investors, highlighting risks in industries like seafood with strong environmental dependencies. This report shares insights from Tasmanian salmon farm visits, exploring ESG risks, investment implications and broader links to nature and climate.
2024 ESG and Sustainability Report Video Overview
Alphinity’s fourth ESG and Sustainability Report outlines our evolving approach to responsible investing, guided by our Five Pillars framework and shaped by nearly 200 company ESG engagements in 2024. This 10-minute video presentation highlights key insights from the report, including updates on material ESG issues, sustainable fund SDG alignment, and enhanced risk assessment tools.
Alphinity Global’s mission to make money for investors
Earnings leadership, company quality and stock valuation is what Trent Masters looks for when picking.
Global Webcast: Key highlights from recent European research trip
Elfreda Jonker and Matisse Clark discuss key takeaways from Matisse’s recent research trip to Europe, where she met with companies across the industrial, consumer and healthcare sectors.
Australian Webcast: UK Technology Trip – growth opportunity for Xero & Technology One
Elfreda Jonker and Andrey Mironenko share insights from a recent UK research trip, exploring opportunities for ASX-listed technology companies Xero and Technology One.
Australian Webcast: Australian banks & consumer staples
Elfreda Jonker reflects on Alphinity’s latest earnings note, highlighting how the team’s disciplined focus on earnings leadership has delivered consistent alpha through volatile markets. She explores key portfolio insights across Australian banks, the Coles versus Woolworths divergence, and insurance, demonstrating the power of earnings upgrades as a performance driver.
